Skip to content

Clinical trials

Coronavirus Infections trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronavirus Infections Phase: Not applicable Clear all

180 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
2020112
202144
202215
20235
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed110
Unknown status35
Terminated15
Withdrawn14
Recruiting3
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Charles Drew University of Medicine and Science3
Institut Pasteur3
Johns Hopkins University3
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.2
Centre Hospitalier Universitaire de Nice2
Centre de recherche du Centre hospitalier universitaire de Sherbrooke2
Dascena2
Dr. Alexander Supady2
Federal University of Paraíba2
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronavirus Infections180
COVID-19112
Severe Acute Respiratory Syndrome16
Respiration Disorders7
Respiratory Distress Syndrome7
Respiratory Insufficiency7
Virus Diseases5
Cytokine Release Syndrome4
Fatigue4
Hypoxia4

Trials

Showing 51 to 75 of 180. Each trial links to its page on Pharma Observatory.

80 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.